ArticleAnnals of the rheumatic diseases2019

Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.

Saba Nayar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.